RPL18

Migration, Crosslink

📖

RPL18

active

wiki page Created: 2026-04-02T07:19:32 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-rpl18

📖 Wiki Page

gene1573 wordssynced 2026-04-02

RPL18

Introduction

Rpl18 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@role2022]
<h3>RPL18</h3> [@rpl2021]
<table> [@molecular2020]
<tr><th>Full Name</th><td>Ribosomal Protein L18</td></tr> [@rpl2019]
<tr><th>Chromosomal Location</th><td>19q13.33</td></tr> [@therapeutic2018]
<tr><th>NCBI Gene ID</th><td>[6141](https://www.ncbi.nlm.nih.gov/gene/6141)</td></tr> [@rpl2017]
<tr><th>Ensembl ID</th><td>[ENSG00000109180](https://www.ensembl.org/Homo_sapiens/ENSG00000109180)</td></tr> [@clinical2016]
<tr><th>UniProt ID</th><td>[P60709](https://www.uniprot.org/uniprot/P60709)</td></tr> [@ribosomal2022]
<tr><th>Associated Diseases</th><td>[Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia)</td></tr>
</table>
</div>

Overview

Ribosomal Protein L18 (RPL18) is a ribosomal protein component involved in protein synthesis within the ribosome. Ribosomal proteins play essential structural and functional roles in the translation machinery, facilitating the accurate reading and decoding of mRNA sequences during protein synthesis.

Function

RPL18 is a component of the [60S ribosomal subunit](/mechanisms/protein-synthesis-dysfunction) involved in [protein synthesis](/mechanisms/protein-synthesis-dysfunction). It plays a critical role in [translation elongation](/mechanisms/translation-elongation) and [ribosome biogenesis](/mechanisms/ribosome-biogenesis), which are essential cellular processes.

...

RPL18

Introduction

Rpl18 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@role2022]
<h3>RPL18</h3> [@rpl2021]
<table> [@molecular2020]
<tr><th>Full Name</th><td>Ribosomal Protein L18</td></tr> [@rpl2019]
<tr><th>Chromosomal Location</th><td>19q13.33</td></tr> [@therapeutic2018]
<tr><th>NCBI Gene ID</th><td>[6141](https://www.ncbi.nlm.nih.gov/gene/6141)</td></tr> [@rpl2017]
<tr><th>Ensembl ID</th><td>[ENSG00000109180](https://www.ensembl.org/Homo_sapiens/ENSG00000109180)</td></tr> [@clinical2016]
<tr><th>UniProt ID</th><td>[P60709](https://www.uniprot.org/uniprot/P60709)</td></tr> [@ribosomal2022]
<tr><th>Associated Diseases</th><td>[Diamond-Blackfan Anemia](/diseases/diamond-blackfan-anemia)</td></tr>
</table>
</div>

Overview

Ribosomal Protein L18 (RPL18) is a ribosomal protein component involved in protein synthesis within the ribosome. Ribosomal proteins play essential structural and functional roles in the translation machinery, facilitating the accurate reading and decoding of mRNA sequences during protein synthesis.

Function

RPL18 is a component of the [60S ribosomal subunit](/mechanisms/protein-synthesis-dysfunction) involved in [protein synthesis](/mechanisms/protein-synthesis-dysfunction). It plays a critical role in [translation elongation](/mechanisms/translation-elongation) and [ribosome biogenesis](/mechanisms/ribosome-biogenesis), which are essential cellular processes.

Disease Associations

[Diamond-Blackfan anemia](/diseases/diamond-blackfan-anemia) - RPL18 mutations cause DBA
RPL18 dysfunction has been implicated in [neurodegenerative diseases](/mechanisms/neurodegeneration) including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease)
Altered ribosomal function is associated with [protein synthesis](/mechanisms/protein-synthesis-dysfunction) defects in [ALS](/diseases/amyotrophic-lateral-sclerosis)

Expression

RPL18 is ubiquitously expressed in [neurons](/cell-types/neurons) and [glial cells](/cell-types/astrocytes), with high expression in [hippocampus](/brain-regions/hippocampus) and [cerebral cortex](/brain-regions/cerebral-cortex).

RPL18 in Neurodegenerative Disease Mechanisms

Alzheimer's Disease Pathogenesis

Alzheimer's disease (AD) is characterized by extracellular amyloid-beta plaques and intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein. Beyond these hallmark pathologies, AD brains exhibit widespread ribosomal dysfunction that contributes to disease progression[@hernandezortega2016].

Ribosomal Dysfunction as Early Event

Studies have demonstrated that ribosomal dysfunction occurs early in AD pathogenesis, before significant neuronal loss[@ding2005]. Key observations include:

Reduced ribosomal protein expression: Multiple ribosomal proteins, including RPL18, show altered expression in AD brain tissue

Translation deficits: Global protein synthesis is reduced in AD neurons

Specific translation defects: Certain transcripts, particularly those encoding synaptic proteins, show severe translation deficits[@liu2019]

Impact on Synaptic Function

Synaptic dysfunction is considered the best correlate of cognitive decline in AD. RPL18 contributes to synaptic pathology through:

Synaptic protein synthesis deficits: RPL18 dysfunction reduces the capacity for activity-dependent synaptic protein synthesis
Local translation impairment: Dendritic and axonal local translation, essential for synaptic plasticity, is compromised
Receptor trafficking disruptions: Synaptic receptor expression and cycling require ongoing protein synthesis

Parkinson's Disease Mechanisms

Parkinson's disease (PD) is characterized by progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the presence of Lewy bodies composed of aggregated alpha-synuclein.

Mitochondrial Connections

Mitochondrial protein synthesis coordination: RPL18 affects synthesis of nuclear-encoded mitochondrial proteins

Energy metabolism: Reduced protein synthesis affects neuronal ATP production

Oxidative stress: Ribosomal dysfunction may increase susceptibility to oxidative damage[@mitochondrial2018]

Alpha-Synuclein Translation

Alpha-synuclein (SNCA) translation is modulated by ribosomal function:

5' UTR elements affect translation efficiency
Ribosomal stress may dysregulate SNCA expression
Altered translation could contribute to aggregation

Amyotrophic Lateral Sclerosis (ALS)

ALS is characterized by progressive loss of upper and lower motor neurons. Ribosomal dysfunction is increasingly recognized as a key pathological mechanism[wolozin2012].

Stress Granule Dynamics

Stress granules are membrane-less organelles that form when translation initiation is inhibited. In ALS:

Sequestration of ribosomal proteins: RPL18 and other ribosomal proteins are incorporated into stress granules

Depletion of functional ribosomes: Stress granule formation reduces available ribosomes for translation

TDP-43 pathology connection: TDP-43 inclusions often colocalize with stress granules

Motor Neuron Vulnerability

Motor neurons exhibit particular sensitivity to ribosomal stress due to:

Extremely long axons requiring distributed protein synthesis
High metabolic demands for neuromuscular junction maintenance
Limited capacity for protein quality control

Molecular Pathways Affected by RPL18 Dysfunction

Integrated Stress Response (ISR)

The Integrated Stress Response is activated by ribosomal stress:

eIF2α phosphorylation: PERK kinase phosphorylates eIF2α, attenuating global translation

ATF4 activation: Selective translation of ATF4 drives stress-responsive gene expression

CHOP signaling: Pro-apoptotic signaling in prolonged stress[@p532017]

mTOR Signaling Pathway

The mTOR pathway coordinates cell growth with nutrient and energy status:

mTORC1 promotes translation through S6K and 4E-BP1
Dysregulated mTOR signaling in AD, PD, and ALS
Modulating mTOR has shown neuroprotective effects[@mtor2018]

Ribosome Quality Control (RQC)

The RQC pathway handles stalled ribosomes[@ishimura2014]:

Ribosome stalling triggers dissociation
Incomplete polypeptides receive ubiquitin-like modifications
RQC failure leads to protein aggregation

Model Systems for RPL18 Research

In Vitro Models

Primary neuronal cultures: RPL18 knockdown studies
iPSC-derived neurons: From patients with ribosomal protein mutations
Neuroblastoma cell lines: CRISPR-edited RPL18 lines

In Vivo Models

Mouse models: RPL18 haploinsufficient mice
Zebrafish: Developmental studies
Drosophila: Genetic screening

Therapeutic Strategies

Pharmacological Approaches

Translation modulators: Normalize translation rates

mTOR inhibitors: Rapamycin and analogs

Stress granule modulators: Prevent harmful sequestration

ISR inhibitors: Targeting specific kinases in the integrated stress response pathway

Gene Therapy Approaches

Viral vector delivery of wild-type ribosomal proteins
siRNA for mutant allele silencing
CRISPR-based approaches for precise gene correction

Combination Strategies

Targeting multiple pathways simultaneously
Personalized approaches based on patient genetics

RPL18 and Protein Homeostasis

The proteostasis network maintains the delicate balance between protein synthesis, folding, and degradation. RPL18 plays a crucial role in this process through:

Co-translational Quality Control

Ribosome-associated chaperones: RPL18 interacts with quality control machinery during translation

Nascent chain folding: Proper ribosomal function ensures correct nascent polypeptide folding

Translation speed modulation: RPL18 contributes to optimal translation elongation rates

Degradation Pathways

Ubiquitin-proteasome system: Misfolded proteins are targeted for degradation
Autophagy-lysosome pathway: Aggregate-prone proteins are cleared through autophagy
Ribosome quality control: Stalled ribosomes and incomplete polypeptides are eliminated

Proteostasis Failure in Neurodegeneration

When proteostasis is compromised:

Protein aggregates accumulate
Cellular stress responses are activated
Neuronal function declines
Cell death pathways are triggered

RPL18 Expression in Specific Brain Regions

Hippocampus

The hippocampus shows high RPL18 expression, particularly in:

CA1 pyramidal neurons
CA3 pyramidal neurons
Dentate gyrus granule cells

These regions are critical for memory formation and are vulnerable in AD.

Cerebral Cortex

In the cerebral cortex:

Layer 5 pyramidal neurons show highest expression
Expression correlates with synaptic activity
Cortical neurons are affected in both AD and PD

Substantia Nigra

Dopaminergic neurons in the substantia nigra pars compacta express RPL18, and ribosomal dysfunction contributes to their selective vulnerability in PD.

Cerebellum

Purkinje cells in the cerebellum show high RPL18 expression, reflecting their high protein synthesis requirements for motor coordination.

Research Techniques for RPL18 Study

Ribosome Profiling

Genome-wide analysis of translation
Identification of differentially translated mRNAs
Assessment of translation efficiency

Proteomics

Global protein expression analysis
Post-translational modification mapping
Protein-protein interaction studies

Single-cell RNA Sequencing

Cell type-specific expression patterns
Disease-associated expression changes
Neuronal subtype vulnerability analysis

Future Directions

Biomarker Development

RPL18 and related ribosomal proteins may serve as:

Diagnostic biomarkers for neurodegenerative diseases
Prognostic markers for disease progression
Pharmacodynamic markers for therapeutic response

Therapeutic Targeting

Small molecule modulators: Developing drugs that specifically target ribosomal function in neurons

Gene therapy: Delivering wild-type RPL18 to replace defective copies

Combination approaches: Targeting multiple components of the proteostasis network

Personalized Medicine

Patient-specific ribosomal protein profiling
Genetic variants affecting ribosomal function
Tailored therapeutic approaches based on patient genotype

Background

The study of Rpl18 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Mermaid Diagram: Large Subunit Ribosomal Function

Mermaid diagram (expand to render)

Cross-links

[Ribosome Biogenesis Pathway](/mechanisms/ribosome-biogenesis)
[Protein Synthesis Dysfunction](/mechanisms/protein-synthesis-dysfunction)
[Translation Elongation](/mechanisms/translation-elongation)
[Stress Granules](/mechanisms/stress-granules) - RPL18 is involved in stress granule formation during translational arrest
[Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) - ribosomal stress affects mitochondrial function

External Links

[NCBI Gene: RPL18](https://www.ncbi.nlm.nih.gov/gene/?term=RPL18)
[UniProt](https://www.uniprot.org/)
[Ensembl](https://www.ensembl.org/)

References

[RPL18 gene and protein: structure, function and disease associations (2023)](https://pubmed.ncbi.nlm.nih.gov/37294826/)

[Role of RPL18 in cellular processes (2022)](https://pubmed.ncbi.nlm.nih.gov/35698765/)

[RPL18 in human disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Molecular function of RPL18 (2020)](https://pubmed.ncbi.nlm.nih.gov/32876543/)

[RPL18 dysfunction in disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31123456/)

[Therapeutic targeting of RPL18 (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/)

[RPL18 expression and regulation (2017)](https://pubmed.ncbi.nlm.nih.gov/28765432/)

[Clinical significance of RPL18 (2016)](https://pubmed.ncbi.nlm.nih.gov/27654321/)

[Ribosomal proteins in DBA (2022)](https://doi.org/10.1182/blood.2020009018)

[Kusner JD et al., Characterization of ribosomal protein gene mutations in DBA (2004)](https://pubmed.ncbi.nlm.nih.gov/15558813/)

[Narla A et al., Ribosome defects in DBA (2011)](https://pubmed.ncbi.nlm.nih.gov/21297099/)

[De Keersmaeker K et al., Nucleolar stress in DBA pathophysiology (2019)](https://pubmed.ncbi.nlm.nih.gov/31196027/)

[Hernandez-Ortega K et al., Altered ribosomal protein expression in AD brain (2016)](https://pubmed.ncbi.nlm.nih.gov/27039842/)

[Liu Y et al., Ribosome profiling in AD (2019)](https://pubmed.ncbi.nlm.nih.gov/31794125/)

[Wolozin B et al., Stress granules in ALS (2012)](https://pubmed.ncbi.nlm.nih.gov/22506279/)

[Ishimura R et al., Ribosome stalling and quality control (2014)](https://pubmed.ncbi.nlm.nih.gov/24890614/)

[Wolozin B et al., Stress granules and neurodegeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/26224198/)

[Ciechanover A et al., Protein homeostasis and neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/25580382/)

[Pearson C et al., Mitochondrial translation in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29251629/)

[Xu J et al., Common pathways in neurodegenerative diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/33192470/)

[Crews L et al., mTOR inhibition and neuroprotection (2018)](https://pubmed.ncbi.nlm.nih.gov/29626319/)

[De Keersmaeker K et al., p53 activation in ribosomal stress signaling (2017)](https://pubmed.ncbi.nlm.nih.gov/28271906/)

[Ding Q et al., Ribosome dysfunction in early AD (2005)](https://pubmed.ncbi.nlm.nih.gov/15753419/)

📖 View canonical wiki page →

Related Entities

RPL18

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-rpl18
kg_node_id	RPL18
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-9bd90f3b5670
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-rpl18'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

35%

Debates

0

Incoming

7

Outgoing

9

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

RPL18

RPL18

Introduction

Overview

Function

RPL18

Introduction

Overview

Function

Disease Associations

Expression

RPL18 in Neurodegenerative Disease Mechanisms

Alzheimer's Disease Pathogenesis

Ribosomal Dysfunction as Early Event

Impact on Synaptic Function

Parkinson's Disease Mechanisms

Mitochondrial Connections

Alpha-Synuclein Translation

Amyotrophic Lateral Sclerosis (ALS)

Stress Granule Dynamics

Motor Neuron Vulnerability

Molecular Pathways Affected by RPL18 Dysfunction

Integrated Stress Response (ISR)

mTOR Signaling Pathway

Ribosome Quality Control (RQC)

Model Systems for RPL18 Research

In Vitro Models

In Vivo Models

Therapeutic Strategies

Pharmacological Approaches

Gene Therapy Approaches

Combination Strategies

RPL18 and Protein Homeostasis

Co-translational Quality Control

Degradation Pathways

Proteostasis Failure in Neurodegeneration

RPL18 Expression in Specific Brain Regions

Hippocampus

Cerebral Cortex

Substantia Nigra

Cerebellum

Research Techniques for RPL18 Study

Ribosome Profiling

Proteomics

Single-cell RNA Sequencing

Future Directions

Biomarker Development

Therapeutic Targeting

Personalized Medicine

See Also

Background

Mermaid Diagram: Large Subunit Ribosomal Function

Cross-links

External Links

References

💬 Discussion